Owkin Closes Series A Funding Round

▤ Summary

Owkin , a NYC-based company which builds machine learning technologies and infrastructure to enable medical research, received a funding round of undisclosed amount. The company intends to use the funds to expand its partner network worldwide and deploy its flagship machine learning platform to augment medical research. Founded in 2016 by Thomas Clozel M.D., CEO, Owkin builds machine learning technologies to enable medical and scientific discoveries. These algorithms support drug development by predicting treatment outcomes and disease evolution. Owkin’s network enables federated learning for the healthcare industry, allowing researchers to train predictive models on heterogeneous real-world data while preserving patient privacy.

▦ Linked Companies